These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 12877005)

  • 41. Serotonin syndrome: a brief review.
    Birmes P; Coppin D; Schmitt L; Lauque D
    CMAJ; 2003 May; 168(11):1439-42. PubMed ID: 12771076
    [No Abstract]   [Full Text] [Related]  

  • 42. As-needed use of cyproheptadine for treatment of selective serotonin reuptake inhibitor-related female anorgasmia.
    Javanbakht A
    J Clin Psychopharmacol; 2015 Feb; 35(1):91-3. PubMed ID: 25502486
    [No Abstract]   [Full Text] [Related]  

  • 43. The serotonin syndrome.
    Boyer EW; Shannon M
    N Engl J Med; 2005 Mar; 352(11):1112-20. PubMed ID: 15784664
    [No Abstract]   [Full Text] [Related]  

  • 44. Serotonin syndrome in a patient taking Lexapro and Flexeril: a case report.
    Day LT; Jeanmonod RK
    Am J Emerg Med; 2008 Nov; 26(9):1069.e1-3. PubMed ID: 19091289
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mild serotonin syndrome on fluvoxamine.
    Kaneda Y; Ishimoto Y; Ohmori T
    Int J Neurosci; 2001 Aug; 109(3-4):165-72. PubMed ID: 11699328
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The FDA alert on serotonin syndrome with combined use of SSRIs or SNRIs and Triptans: an analysis of the 29 case reports.
    Evans RW
    MedGenMed; 2007 Sep; 9(3):48. PubMed ID: 18092054
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An acute neurological syndrome with cerebrovascular and parkinsonian clinical features associated with perioperative SNRI withdrawal.
    Williams GW; Gandhi SJ; Altamirano A
    J Neurosurg Anesthesiol; 2013 Jul; 25(3):353-4. PubMed ID: 23552278
    [No Abstract]   [Full Text] [Related]  

  • 48. Serotonin syndrome precipitated by sertraline and discontinuation of clozapine.
    Srisuma S; Hoyte CO; Wongvisavakorn S; Wanaukul W
    Clin Toxicol (Phila); 2015; 53(8):840-1. PubMed ID: 26161840
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of the serotonin and noradrenaline reuptake inhibitor (SNRI) milnacipran on marble burying behavior in mice.
    Sugimoto Y; Tagawa N; Kobayashi Y; Hotta Y; Yamada J
    Biol Pharm Bull; 2007 Dec; 30(12):2399-401. PubMed ID: 18057733
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative studies with milnacipran and tricyclic antidepressants in the treatment of patients with major depression: a summary of clinical trial results.
    Kasper S; Pletan Y; Solles A; Tournoux A
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():35-9. PubMed ID: 8923125
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Life-threatening serotonin syndrome following a single dose of a serotonin reuptake inhibitor during maintenance therapy with a monoamine oxidase inhibitor].
    Güzelcan Y; Kleinpenning AS
    Ned Tijdschr Geneeskd; 2006 Aug; 150(31):1748; author reply 1748-9. PubMed ID: 16927475
    [No Abstract]   [Full Text] [Related]  

  • 52. Comment: serotonin syndrome, mydriasis, and cyproheptadine.
    Isbister GK
    Ann Pharmacother; 2001 Dec; 35(12):1672-3. PubMed ID: 11793643
    [No Abstract]   [Full Text] [Related]  

  • 53. Effects of milnacipran and fluvoxamine on hyperemotional behaviors and the loss of tryptophan hydroxylase-positive cells in olfactory bulbectomized rats.
    Saitoh A; Yamaguchi K; Tatsumi Y; Murasawa H; Nakatani A; Hirose N; Yamada M; Yamada M; Kamei J
    Psychopharmacology (Berl); 2007 May; 191(4):857-65. PubMed ID: 17318509
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comment: serotonin syndrome induced by fluvoxamine and mirtazapine.
    Isbister GK; Dawson AH; Whyte IM
    Ann Pharmacother; 2001 Dec; 35(12):1674-5. PubMed ID: 11793645
    [No Abstract]   [Full Text] [Related]  

  • 55. Serotonin syndrome risks when combining SSRI/SNRI drugs and triptans: is the FDA's alert warranted?
    Wenzel RG; Tepper S; Korab WE; Freitag F
    Ann Pharmacother; 2008 Nov; 42(11):1692-6. PubMed ID: 18957623
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and tolerability of milnacipran: an overview.
    Montgomery SA; Prost JF; Solles A; Briley M
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():47-51. PubMed ID: 8923127
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of milnacipran and paroxetine on overactive bladder due to neurologic diseases: a urodynamic assessment.
    Sakakibara R; Ito T; Uchiyama T; Awa Y; Yamaguchi C; Hattori T
    Urol Int; 2008; 81(3):335-9. PubMed ID: 18931554
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug-Induced Serotonin Syndrome.
    Bartlett D
    Crit Care Nurse; 2017 Feb; 37(1):49-54. PubMed ID: 28148614
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serotonin syndrome in the differential diagnosis of spinal cord compression.
    Whipp MJ; Waterfield KE
    Palliat Med; 2004 Jan; 18(1):69-70. PubMed ID: 14982210
    [No Abstract]   [Full Text] [Related]  

  • 60. 74-year-old woman with new-onset myoclonus.
    Zand L; Hoffman SJ; Nyman MA
    Mayo Clin Proc; 2010 Oct; 85(10):955-8. PubMed ID: 20884828
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.